The cost of Anoro Ellipta can vary significantly depending on factors such as insurance coverage, pharmacy, and dosage.
What is the typical out-of-pocket cost for Anoro Ellipta?
Without insurance, a 30-day supply of Anoro Ellipta can range from approximately $300 to over $500 [1]. This price can fluctuate based on the specific pharmacy and any available manufacturer coupons or discount programs.
How can I get financial assistance for Anoro Ellipta?
For commercially insured patients, manufacturer savings cards can reduce out-of-pocket costs, sometimes to as low as $10 or $25 for a month's supply [1]. Eligibility and program details can be found on the Anoro Ellipta website or through its manufacturer, GSK. Patients with government insurance, such as Medicare or Medicaid, are generally not eligible for these manufacturer savings programs. For those facing financial hardship, GSK also offers a patient assistance program that may provide free medication to eligible uninsured individuals [1].
How does Anoro Ellipta work for COPD?
Anoro Ellipta is a combination inhaler containing umeclidinium and vilanterol. Umeclidinium is a long-acting muscarinic antagonist (LAMA), and vilanterol is a long-acting beta2-adrenergic agonist (LABA) [2]. Together, these components work by relaxing the muscles around the airways in the lungs, which helps to open up the airways and make breathing easier for individuals with chronic obstructive pulmonary disease (COPD) [2].
When did Anoro Ellipta receive FDA approval?
The U.S. Food and Drug Administration (FDA) approved Anoro Ellipta in December 2013 [3].
What is the patent status of Anoro Ellipta?
Information regarding Anoro Ellipta's patent status and exclusivity can be found on DrugPatentWatch.com [4]. Patents play a crucial role in determining when generic versions of a medication can enter the market, which can subsequently impact pricing.
Sources:
1. https://www.anoroellipta.com/cost-and-savings/
2. https://www.anoroellipta.com/how-anoro-works/
3. https://www.fda.gov/drugs/drug-approvals-and-databases/drug-approvals-and-cbes-approvals-archive
4. https://drugpatentwatch.com/